Collectively, our study establishes the critical role of NK cells in mediating immunotherapy response in HR<sup>+</sup>/HER2<sup>-</sup> breast cancer and uncovers a novel mechanism whereby platinum agents augment immunotherapeutic efficacy, offering a promising combination strategy. Here, ERBB2 is linked to breast carcinoma.